839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

Bibliographic Details
Main Authors: Amanda G Powell, Indu Venugopal, Morgan N DeLong, Shelby Knoche, Michael J McGuire, Kathlynn C Brown
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items